 | • レポートコード：QYR9ST05284 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、肝炎治療薬の世界市場について調査・分析し、肝炎治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（肝炎ワクチン、抗ウイルス薬）、用途別（A型肝炎、B型肝炎、C型肝炎、アルコール性肝炎、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の肝炎治療薬市場動向 ・主要企業別マーケットシェア ・肝炎治療薬の種類別市場規模2014-2019 （肝炎ワクチン、抗ウイルス薬） ・肝炎治療薬の用途別市場規模2014-2019 （A型肝炎、B型肝炎、C型肝炎、アルコール性肝炎、その他） ・肝炎治療薬の北米市場：主要企業・種類別/用途別市場規模 ・肝炎治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・肝炎治療薬の中国市場：主要企業・種類別/用途別市場規模 ・肝炎治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・肝炎治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・肝炎治療薬のインド市場：主要企業・種類別/用途別市場規模 ・肝炎治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Gilead、Johnson & Johnson、Bristol-Myers Squibb Company、Merck & Co.Inc.、AbbVie Inc.） ・肝炎治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and will continously increase.
In 2018, the global Hepatitis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hepatitis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis Therapeutics development in United States, Europe and China.
The key players covered in this study
Gilead
Johnson & Johnson
Bristol-Myers Squibb Company
Merck & Co.Inc.
AbbVie Inc.
…
Market segment by Type, the product can be split into
Hepatitis Vaccine
Anti-Viral Drugs
Market segment by Application, split into
Hepatitis A
Hepatitis B
Hepatitis C
Alcoholic Hepatitis
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hepatitis Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Hepatitis Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hepatitis Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hepatitis Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Hepatitis Vaccine
1.4.3 Anti-Viral Drugs
1.5 Market by Application
1.5.1 Global Hepatitis Therapeutics Market Share by Application (2014-2025)
1.5.2 Hepatitis A
1.5.3 Hepatitis B
1.5.4 Hepatitis C
1.5.5 Alcoholic Hepatitis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hepatitis Therapeutics Market Size
2.2 Hepatitis Therapeutics Growth Trends by Regions
2.2.1 Hepatitis Therapeutics Market Size by Regions (2014-2025)
2.2.2 Hepatitis Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hepatitis Therapeutics Market Size by Manufacturers
3.1.1 Global Hepatitis Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Hepatitis Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hepatitis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Hepatitis Therapeutics Key Players Head office and Area Served
3.3 Key Players Hepatitis Therapeutics Product/Solution/Service
3.4 Date of Enter into Hepatitis Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hepatitis Therapeutics Market Size by Type (2014-2019)
4.2 Global Hepatitis Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Hepatitis Therapeutics Market Size (2014-2019)
5.2 Hepatitis Therapeutics Key Players in United States
5.3 United States Hepatitis Therapeutics Market Size by Type
5.4 United States Hepatitis Therapeutics Market Size by Application
6 Europe
6.1 Europe Hepatitis Therapeutics Market Size (2014-2019)
6.2 Hepatitis Therapeutics Key Players in Europe
6.3 Europe Hepatitis Therapeutics Market Size by Type
6.4 Europe Hepatitis Therapeutics Market Size by Application
7 China
7.1 China Hepatitis Therapeutics Market Size (2014-2019)
7.2 Hepatitis Therapeutics Key Players in China
7.3 China Hepatitis Therapeutics Market Size by Type
7.4 China Hepatitis Therapeutics Market Size by Application
8 Japan
8.1 Japan Hepatitis Therapeutics Market Size (2014-2019)
8.2 Hepatitis Therapeutics Key Players in Japan
8.3 Japan Hepatitis Therapeutics Market Size by Type
8.4 Japan Hepatitis Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hepatitis Therapeutics Market Size (2014-2019)
9.2 Hepatitis Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Hepatitis Therapeutics Market Size by Type
9.4 Southeast Asia Hepatitis Therapeutics Market Size by Application
10 India
10.1 India Hepatitis Therapeutics Market Size (2014-2019)
10.2 Hepatitis Therapeutics Key Players in India
10.3 India Hepatitis Therapeutics Market Size by Type
10.4 India Hepatitis Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Hepatitis Therapeutics Market Size (2014-2019)
11.2 Hepatitis Therapeutics Key Players in Central & South America
11.3 Central & South America Hepatitis Therapeutics Market Size by Type
11.4 Central & South America Hepatitis Therapeutics Market Size by Application
12 International Players Profiles
12.1 Gilead
12.1.1 Gilead Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hepatitis Therapeutics Introduction
12.1.4 Gilead Revenue in Hepatitis Therapeutics Business (2014-2019)
12.1.5 Gilead Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hepatitis Therapeutics Introduction
12.2.4 Johnson & Johnson Revenue in Hepatitis Therapeutics Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Bristol-Myers Squibb Company
12.3.1 Bristol-Myers Squibb Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hepatitis Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Company Revenue in Hepatitis Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Company Recent Development
12.4 Merck & Co.Inc.
12.4.1 Merck & Co.Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hepatitis Therapeutics Introduction
12.4.4 Merck & Co.Inc. Revenue in Hepatitis Therapeutics Business (2014-2019)
12.4.5 Merck & Co.Inc. Recent Development
12.5 AbbVie Inc.
12.5.1 AbbVie Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hepatitis Therapeutics Introduction
12.5.4 AbbVie Inc. Revenue in Hepatitis Therapeutics Business (2014-2019)
12.5.5 AbbVie Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hepatitis Therapeutics Key Market Segments
Table Key Players Hepatitis Therapeutics Covered
Table Global Hepatitis Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hepatitis Therapeutics Market Size Market Share by Type 2014-2025
Figure Hepatitis Vaccine Figures
Table Key Players of Hepatitis Vaccine
Figure Anti-Viral Drugs Figures
Table Key Players of Anti-Viral Drugs
Table Global Hepatitis Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hepatitis A Case Studies
Figure Hepatitis B Case Studies
Figure Hepatitis C Case Studies
Figure Alcoholic Hepatitis Case Studies
Figure Others Case Studies
Figure Hepatitis Therapeutics Report Years Considered
Table Global Hepatitis Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Hepatitis Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hepatitis Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Hepatitis Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Hepatitis Therapeutics Market Share by Regions 2014-2019
Figure Global Hepatitis Therapeutics Market Share by Regions 2014-2019
Figure Global Hepatitis Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Hepatitis Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hepatitis Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Hepatitis Therapeutics Market Share by Manufacturers in 2018
Table Global Hepatitis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hepatitis Therapeutics Product/Solution/Service
Table Date of Enter into Hepatitis Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hepatitis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Hepatitis Therapeutics Market Size Share by Type (2014-2019)
Figure Global Hepatitis Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Hepatitis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Hepatitis Therapeutics Market Size Share by Application (2014-2019)
Figure Global Hepatitis Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Hepatitis Therapeutics Revenue Market Share by Application in 2018
Figure United States Hepatitis Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Hepatitis Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Hepatitis Therapeutics Market Share (2018-2019)
Table United States Hepatitis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Hepatitis Therapeutics Market Share by Type (2014-2019)
Table United States Hepatitis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Hepatitis Therapeutics Market Share by Application (2014-2019)
Figure Europe Hepatitis Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Hepatitis Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Hepatitis Therapeutics Market Share (2018-2019)
Table Europe Hepatitis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Hepatitis Therapeutics Market Share by Type (2014-2019)
Table Europe Hepatitis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Hepatitis Therapeutics Market Share by Application (2014-2019)
Figure China Hepatitis Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Hepatitis Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Hepatitis Therapeutics Market Share (2018-2019)
Table China Hepatitis Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Hepatitis Therapeutics Market Share by Type (2014-2019)
Table China Hepatitis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Hepatitis Therapeutics Market Share by Application (2014-2019)
Figure Japan Hepatitis Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Hepatitis Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Hepatitis Therapeutics Market Share (2018-2019)
Table Japan Hepatitis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Hepatitis Therapeutics Market Share by Type (2014-2019)
Table Japan Hepatitis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Hepatitis Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Hepatitis Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hepatitis Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hepatitis Therapeutics Market Share (2018-2019)
Table Southeast Asia Hepatitis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hepatitis Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Hepatitis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hepatitis Therapeutics Market Share by Application (2014-2019)
Figure India Hepatitis Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Hepatitis Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Hepatitis Therapeutics Market Share (2018-2019)
Table India Hepatitis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Hepatitis Therapeutics Market Share by Type (2014-2019)
Table India Hepatitis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Hepatitis Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Hepatitis Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hepatitis Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hepatitis Therapeutics Market Share (2018-2019)
Table Central & South America Hepatitis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hepatitis Therapeutics Market Share by Type (2014-2019)
Table Central & South America Hepatitis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hepatitis Therapeutics Market Share by Application (2014-2019)
Table Gilead Company Details
Table Gilead Revenue in Hepatitis Therapeutics Business (2014-2019) (Million US$)
Figure Gilead Revenue Growth Rate in Hepatitis Therapeutics Business (2014-2019)
Table Gilead Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Hepatitis Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Hepatitis Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Hepatitis Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Hepatitis Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Merck & Co.Inc. Company Details
Table Merck & Co.Inc. Revenue in Hepatitis Therapeutics Business (2014-2019)(Million US$)
Figure Merck & Co.Inc. Revenue Growth Rate in Hepatitis Therapeutics Business (2014-2019)
Table Merck & Co.Inc. Recent Development
Table AbbVie Inc. Company Details
Table AbbVie Inc. Revenue in Hepatitis Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie Inc. Revenue Growth Rate in Hepatitis Therapeutics Business (2014-2019)
Table AbbVie Inc. Recent Development
Table Global Hepatitis Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Hepatitis Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Hepatitis Therapeutics Market Size Share by Regions in 2025
Figure United States Hepatitis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hepatitis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Hepatitis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hepatitis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hepatitis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Hepatitis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hepatitis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Hepatitis Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Hepatitis Therapeutics Market Size by Product (2019-2025)
Figure Global Hepatitis Therapeutics Market Size by Product in 2025
Table Global Hepatitis Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Hepatitis Therapeutics Market Size by Application (2019-2025)
Figure Global Hepatitis Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
肝炎治療薬の世界市場：市場規模・現状・予測 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and w…- C型肝炎ウイルス及び治療薬の世界市場：市場規模・現状・予測 Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinomaIn 2018, the global Hepatitis C Virus And Therapeutics market size was xx million US$ and it is ex…
- アルコール性肝炎治療薬の世界市場：市場規模・現状・予測 Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis. The increasing consumption of alco…
- B型肝炎ウイルス（HBV）の世界市場：市場規模・現状・予測 Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…
- アルコール性肝炎治療薬の世界市場：市場規模・現状・予測 Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually …